Literature DB >> 30529659

High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.

Natalia Ehrenhaus Masotta1, Manuela R Martinefski2, Silvia Lucangioli3, Ana M Rojas4, Valeria P Tripodi3.   

Abstract

Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5-50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic, water-insoluble, and poorly absorbed in the gut. Here, CoQ10 showed low bulk density, another important disadvantage in solid oral formulations. Thus, we propose the use of oleogels to maintain dissolved a high-dose of CoQ10 in medium-chain triglyceride (MCT) oil, using ethylcellulose (EC) for gelling, and a surfactant (sorbitan monostearate -SMS- or lecithin). "True gels" were only obtained with the surfactant presence. Thermoreversible oleogels with 1 g of dissolved CoQ10 per 5 g-disk were successfully developed with proved stability and solubility for 12 months (25.0 °C). SMS was better than lecithin as a surfactant because it allowed lower syneresis, higher CoQ10 retention for 12 months, and notably higher oxidative-stability of the MCT-oil, best immobilized by its true gel network. Plastic deformation without fracture was determined under compression, emulating the soft deformation behavior inside the mouth. SMS-oleogels allowed loading a maximal solubilized CoQ10 dose with maximal stability, and may be easier to swallow by CoQ10-deficient patients who suffer from secondary dysphagia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coenzyme Q10 (PubChem CID: 9962735); Coenzyme Q10 stability; Coenzyme Q10 treatment; Dynamic rheology; Dysphagia; Ethylcellulose; Ethylcellulose (PubChem CID: 24832091); High-dose coenzyme Q10; Lecithin from soybean (PubChem CID: 57369748); MCT oil (PubChem CID: 93356); Oleogels; SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928)

Mesh:

Substances:

Year:  2018        PMID: 30529659     DOI: 10.1016/j.ijpharm.2018.12.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Mitochondrial disorders and drugs: what every physician should know.

Authors:  Daniele Orsucci; Elena Caldarazzo Ienco; Gabriele Siciliano; Michelangelo Mancuso
Journal:  Drugs Context       Date:  2019-07-04

Review 2.  Atherosclerosis and Coenzyme Q10.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Mario de la Mata; Marina Villanueva-Paz; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; Manuel Munuera; José A Sánchez-Alcázar
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

Review 3.  Coenzyme Q10: Novel Formulations and Medical Trends.

Authors:  Carmen J Pastor-Maldonado; Juan M Suárez-Rivero; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Manuel Munuera-Cabeza; Alejandra Suárez-Carrillo; Marta Talaverón-Rey; José A Sánchez-Alcázar
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 4.  The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions.

Authors:  Francesco Pallotti; Christian Bergamini; Costanza Lamperti; Romana Fato
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 5.  Primary Coenzyme Q10 Deficiency-7 and Pathogenic COQ4 Variants: Clinical Presentation, Biochemical Analyses, and Treatment.

Authors:  Jieqiong Xie; Jiayang Jiang; Qiwei Guo
Journal:  Front Genet       Date:  2022-01-26       Impact factor: 4.599

Review 6.  Ubisol-Q10, a Nanomicellar and Water-Dispersible Formulation of Coenzyme-Q10 as a Potential Treatment for Alzheimer's and Parkinson's Disease.

Authors:  Darcy Wear; Caleb Vegh; Jagdeep K Sandhu; Marianna Sikorska; Jerome Cohen; Siyaram Pandey
Journal:  Antioxidants (Basel)       Date:  2021-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.